Home Cart Sign in  
Chemical Structure| 81-27-6 Chemical Structure| 81-27-6

Structure of Sennoside A
CAS No.: 81-27-6

Chemical Structure| 81-27-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sennoside A, a kind of irritant laxative isolated from rhei rhizome, causes purgative actions in the intestine.

Synonyms: NSC 112929

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sennoside A

CAS No. :81-27-6
Formula : C42H38O20
M.W : 862.74
SMILES Code : O=C(C(C=C1[C@H]([C@@H]2C3=C(C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)=CC=C3)C(C5=C(O)C=C(C(O)=O)C=C25)=O)C6=C7C(O[C@H]8[C@@H]([C@H]([C@@H]([C@@H](CO)O8)O)O)O)=CC=C6)=CC(O)=C1C7=O)O
Synonyms :
NSC 112929
MDL No. :MFCD00151527
InChI Key :IPQVTOJGNYVQEO-KGFNBKMBSA-N
Pubchem ID :73111

Safety of Sennoside A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • MAO

    MAO, IC50:17 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
NCI-H716 cells 100 μM 24 h To investigate the effect of Sennoside A on palmitic acid-induced stress responses in L-cells. Results showed that Sennoside A blocked PA-induced apoptosis and mitochondrial membrane potential reduction, and reduced ATP elevation. Acta Pharm Sin B. 2019 Jul;9(4):758-768.
Pseudomonas aeruginosa PAO1 50 and 100 mg/ml 24 h To evaluate the effect of Sennoside A on the growth of PAO1, results showed that 50 and 100 mg/ml of Sennoside A did not inhibit the growth of PAO1. Front Microbiol. 2022 Nov 3;13:1042214.
SMMC-7721 cells 25 μM, 50 μM, 100 μM 24 h and 48 h SA had no significant effect on the proliferation of SMMC-7721 cells Front Pharmacol. 2021 Jan 12;11:566099.
HepG2 cells 25 μM, 50 μM, 100 μM 24 h and 48 h SA inhibited the proliferation of HepG2 cells in a concentration-dependent manner Front Pharmacol. 2021 Jan 12;11:566099.
C8166 cells 2.27 μM 72 h To evaluate the inhibitory effect of Sennoside A on HIV-1-induced cytopathic effects, the results showed an IC50 value of 2.27 μM. Front Microbiol. 2023 Sep 25;14:1270258.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice High-fat diet-induced obese model Drinking water 30 mg/kg Once daily for 8 weeks To investigate the effect of Sennoside A on insulin sensitivity in high-fat diet-induced obese mice. Results showed that Sennoside A improved insulin sensitivity, restored plasma GLP1 levels and Glp1 mRNA expression in the colon, and restored gut microbiota and colonic mucosal structure. Acta Pharm Sin B. 2019 Jul;9(4):758-768.
Chinese cabbage, Drosophila melanogaster, Caenorhabditis elegans Chinese cabbage infection model, Drosophila melanogaster infection model, Caenorhabditis elegans infection model Added to the culture medium 50 and 100 mg/ml Single administration, lasting 12 hours To evaluate the effect of Sennoside A on the pathogenicity of PAO1, results showed that Sennoside A significantly reduced the infection area of PAO1 in Chinese cabbage and increased the survival rate of Drosophila melanogaster and Caenorhabditis elegans. Front Microbiol. 2022 Nov 3;13:1042214.
BALB/c nude mice Orthotopic xenograft tumor model Intraperitoneal injection 10 mg/kg Once daily for 14 days SA significantly inhibited the growth and intrahepatic metastasis of HepG2-Luciferase cells Front Pharmacol. 2021 Jan 12;11:566099.
Rats Constipation model Oral 0.1 mg/kg Once daily for 7 days To evaluate the effect of Sennoside A on constipation model rats, the results showed that Sennoside A significantly improved constipation symptoms. Pharm Biol. 2021 Dec;59(1):1452-1463

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.16mL

0.23mL

0.12mL

5.80mL

1.16mL

0.58mL

11.59mL

2.32mL

1.16mL

References

 

Historical Records

Categories